MediWound (MDWD) Liabilities and Shareholders Equity (2016 - 2026)
MediWound (MDWD) posted quarterly Liabilities and Shareholders Equity of $86.3 million for Q4 2025, up 17.36% year-over-year from $73.5 million in Q4 2024, and down 8.65% quarter-over-quarter from $94.4 million in Q3 2025.
MediWound (MDWD) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
MediWound's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $86.3 million for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity rose 17.36% year-over-year to $86.3 million; the TTM figure through Dec 2025 stood at $316.7 million (up 18.21% YoY), while the FY2025 annual figure was $86.3 million, up 17.36% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $86.3 million, down from $94.4 million in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $94.4 million in Q3 2025, with the low at $19.7 million in Q4 2021.
- The 5-year median for Liabilities and Shareholders Equity is $63.4 million (2023), against an average of $53.8 million.
- The sharpest annual moves came in 2021 and 2023: Liabilities and Shareholders Equity plunged 36.45% in 2021, then jumped 204.97% in 2023.
- MediWound's Liabilities and Shareholders Equity stood at $19.7 million in 2021, then soared by 153.32% to $50.0 million in 2022, then surged by 32.88% to $66.5 million in 2023, then advanced by 10.59% to $73.5 million in 2024, then increased by 17.36% to $86.3 million in 2025.
- Business Quant data shows MDWD's Liabilities and Shareholders Equity at $86.3 million in Q4 2025, $94.4 million in Q3 2025, and $67.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | 71.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.88 Mn |
| Dec 31, 2025 | 86.26 Mn |
| Sep 30, 2025 | 94.42 Mn |
| Jun 30, 2025 | 67.00 Mn |
| Mar 31, 2025 | 69.02 Mn |
| Dec 31, 2024 | 73.50 Mn |
| Sep 30, 2024 | 74.73 Mn |
| Jun 30, 2024 | 57.30 Mn |
| Mar 31, 2024 | 62.38 Mn |
| Dec 31, 2023 | 66.46 Mn |
| Sep 30, 2023 | 67.02 Mn |
| Jun 30, 2023 | 64.37 Mn |
| Mar 31, 2023 | 68.67 Mn |
| Dec 31, 2022 | 50.02 Mn |
| Sep 30, 2022 | 28.59 Mn |
| Jun 30, 2022 | 21.11 Mn |
| Mar 31, 2022 | 26.37 Mn |
| Dec 31, 2021 | 19.74 Mn |
| Sep 30, 2021 | 23.17 Mn |
| Jun 30, 2021 | 26.20 Mn |